BioXcel Therapeutics (BTAI) Other Non-Current Assets (2018 - 2025)

BioXcel Therapeutics' Other Non-Current Assets history runs 8 years deep, the most recent figure standing at $87000.0 for Q1 2025.

• In Q1 2025, Other Non-Current Assets changed 0.0% year-over-year to $87000.0; the TTM figure through Mar 2025 stood at $87000.0 (changed 0.0% YoY), while the FY2024 annual figure was $87000.0, changed 0.0% from the prior year.
• Other Non-Current Assets was $87000.0 for Q1 2025 at BioXcel Therapeutics, roughly flat from $87000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $1.8 million in Q3 2021 to a low of $86000.0 in Q4 2021.
• Historically, Other Non-Current Assets has averaged $556764.7 across 5 years, with a median of $87000.0 in 2023.
• The sharpest annual moves came in 2021 and 2023: Other Non-Current Assets surged 3096.08% in 2021, then tumbled 90.59% in 2023.
• A 5-year view of Other Non-Current Assets shows it stood at $86000.0 in 2021, then jumped by 975.58% to $925000.0 in 2022, then sank by 90.59% to $87000.0 in 2023, then changed by 0.0% to $87000.0 in 2024, then changed by 0.0% to $87000.0 in 2025.
• The last three Other Non-Current Assets figures came in at $87000.0 (Q1 2025), $87000.0 (Q4 2024), and $87000.0 (Q3 2024), per Business Quant data.